Role of TLR2 Signaling in Innate and Adaptive Responses to Chlamydiae
TLR2 信号传导在衣原体先天性和适应性反应中的作用
基本信息
- 批准号:7762460
- 负责人:
- 金额:$ 27.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:ApoptosisCD4 Positive T LymphocytesCell physiologyCellsChlamydiaChlamydia InfectionsChlamydia trachomatisChronicCicatrixDataDendritic CellsDevelopmentDiseaseEctopic PregnancyEndometrialEpitheliumGenital systemGoalsHigh PrevalenceHumanImmuneImmune Cell ActivationImmune responseIn VitroIncidenceIndividualInfectionInfertilityInflammatoryInflammatory ResponseKnock-outKnockout MiceLongevityMammalian OviductsMediatingModelingMusOperative Surgical ProceduresPathologyPelvic Inflammatory DiseasePlasmidsProteinsRandomizedResearchResolutionRisk EstimateRoleSexually Transmitted DiseasesSignal TransductionSiteSpecimenT-LymphocyteTLR2 geneTestingTissuesToll-Like Receptor 2Womanbasecell typechronic pelvic paincosthealthy volunteerhuman femalein vivomacrophagemenmonocytemouse modelmutantneutrophilnoveloviduct scarringpathogenreproductiveresponse
项目摘要
Chlamydia trachomatis is the leading cause of bacterial sexually transmitted infections worldwide, with
annual related costs exceeding $2 billion. In women, untreated infections may progress to serious
reproductive tract sequela. Chlamydiae to not appear to express proteins that actively induce disease or
tissue damage in the infected host. Rather, the pathology that follows chlamydial infection is the
consequence of an aggressive host inflammatory response. Using the C. muridarum mouse model, we have
shown that the innate pathogen recognition receptor, TLR2, is essential for development of oviduct
pathology. TLR2 gene knock-out (KO) mice do not develop oviduct pathology after chlamydial infection. In
addition, plasmid-deficient C. muridarum that cause an infection in mice of normal intensity and duration fail
to cause oviduct disease and do not stimulate TLR2. Our data indicate that in the presence of TLR2
signaling, chlamydial infection elicits an immune response of greater magnitude than what is needed and
subsequently leads to tissue pathology. In this application we propose to validate our novel model of
chlamydial disease where pathology occurs in response to primary chlamydial infection by one or both of the
following paths: 1) TLR2-mediated hyper-activation of innate immune cells leading to a response that
exceeds what is required for bacterial clearance, ultimately promoting excessive tissue damage and
scarring; 2) TLR2-mediated hyper-activation of the CD4 T cell response. In addition, we propose to advance
our studies beyond the mouse by investigating chlamydial-induced TLR2 signaling and consequential
inflammatory responses in human reproductive tract tissues. Completion of our studies will allow us to
determine: (1) the effect of chlamydia-induced TLR2-dependent signaling on murine innate immune cell
activation in vitro and in vivo, (2) the mechanism by which mouse T cells respond to and resolve a
Chlamydia infection without producing oviduct tissue damage, (3) the contribution of chlamydia-induced
TLR2 activation to the inflammatory response of human reproductive tract tissue.
沙眼衣原体是世界范围内细菌性传播感染的主要原因
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Toni Darville其他文献
Toni Darville的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Toni Darville', 18)}}的其他基金
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
北卡罗来纳大学 - 衣原体疫苗倡议 (UNC-CVI)
- 批准号:
10392970 - 财政年份:2019
- 资助金额:
$ 27.73万 - 项目类别:
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
北卡罗来纳大学 - 衣原体疫苗倡议 (UNC-CVI)
- 批准号:
10392971 - 财政年份:2019
- 资助金额:
$ 27.73万 - 项目类别:
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
北卡罗来纳大学 - 衣原体疫苗倡议 (UNC-CVI)
- 批准号:
10615092 - 财政年份:2019
- 资助金额:
$ 27.73万 - 项目类别:
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
北卡罗来纳大学 - 衣原体疫苗倡议 (UNC-CVI)
- 批准号:
10392972 - 财政年份:2019
- 资助金额:
$ 27.73万 - 项目类别:
Human Responses to Candidate Chlamydial Antigens
人类对候选衣原体抗原的反应
- 批准号:
10615096 - 财政年份:2019
- 资助金额:
$ 27.73万 - 项目类别:
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
北卡罗来纳大学 - 衣原体疫苗倡议 (UNC-CVI)
- 批准号:
9922862 - 财政年份:2019
- 资助金额:
$ 27.73万 - 项目类别:
Human Responses to Candidate Chlamydial Antigens
人类对候选衣原体抗原的反应
- 批准号:
10392973 - 财政年份:2019
- 资助金额:
$ 27.73万 - 项目类别:
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
北卡罗来纳大学 - 衣原体疫苗倡议 (UNC-CVI)
- 批准号:
10615091 - 财政年份:2019
- 资助金额:
$ 27.73万 - 项目类别:
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
北卡罗来纳大学 - 衣原体疫苗倡议 (UNC-CVI)
- 批准号:
10615094 - 财政年份:2019
- 资助金额:
$ 27.73万 - 项目类别:














{{item.name}}会员




